These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7840598)

  • 21. In vitro activities of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood.
    Chang SC; Chen YC; Luh KT; Hsieh WC
    Diagn Microbiol Infect Dis; 1995 Nov; 23(3):105-110. PubMed ID: 8849654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of ampicillin-sulbactam against clinical multiresistant Acinetobacter baumannii isolates.
    Gales AC; Sader HS; Sinto S; Santos OP; Mendes CM
    J Chemother; 1996 Dec; 8(6):416-9. PubMed ID: 8981180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
    Carvalheira A; Casquete R; Silva J; Teixeira P
    Int J Food Microbiol; 2017 Feb; 243():58-63. PubMed ID: 27992816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.
    Jones RN; Pfaller MA; Marshall SA; Hollis RJ; Wilke WW
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):187-92. PubMed ID: 9401811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
    Wang H; Chen MJ;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study.
    Chen J; Li H; Yang J; Zhan R; Chen A; Yan Y
    Int J Environ Res Public Health; 2015 Aug; 12(8):10093-105. PubMed ID: 26308028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of susceptibility of gentamicin-resistant and -susceptible "Acinetobacter anitratus" to 15 alternative antibiotics.
    Stiver HG; Bartlett KH; Chow AW
    Antimicrob Agents Chemother; 1986 Oct; 30(4):624-5. PubMed ID: 3789698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002].
    Akan OA
    Mikrobiyol Bul; 2003 Oct; 37(4):241-6. PubMed ID: 14748260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro evaluation of antimicrobial combinations against imipenem-resistant Acinetobacter baumannii of different MICs.
    Zhu W; Wang Y; Cao W; Cao S; Zhang J
    J Infect Public Health; 2018; 11(6):856-860. PubMed ID: 30057349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
    Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
    Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro investigation of the susceptibility of Acinetobacter baumannii strains isolated from clinical specimens to ampicillin/sulbactam alone and in combination with amikacin.
    Savov E; Chankova D; Vatcheva R; Dinev N
    Int J Antimicrob Agents; 2002 Nov; 20(5):390-2. PubMed ID: 12431877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification and sensitivity of acinetobacter sp isolated from clinical specimens and hospital environment].
    Martínez MA; Pinto ME; Giglio MS; Pommier J; Muñoz LM
    Rev Med Chil; 1992 Nov; 120(11):1267-72. PubMed ID: 1340947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii.
    Choi JY; Park YS; Cho CH; Park YS; Shin SY; Song YG; Yong D; Lee K; Kim JM
    Clin Microbiol Infect; 2004 Dec; 10(12):1098-101. PubMed ID: 15606639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Acinetobacter calcoaceticus to antimicrobial drugs, alone and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1989; 35(2):95-104. PubMed ID: 2758872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000)].
    Fernández-Cuenca F; Pascual A; Ribera A; Vila J; Bou G; Cisneros JM; Rodríguez-Baño J; Pachón J; Martínez-Martínez L;
    Enferm Infecc Microbiol Clin; 2004 May; 22(5):267-71. PubMed ID: 15207117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].
    Wang Q; Zhao CJ; Wang H; Yu YS; Zhu ZH; Chu YZ; Sun ZY; Hu ZD; Xu XL; Liao K; Xu YC; Zhang LY; Mei YN; Yang B; Ni YX
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1388-96. PubMed ID: 24025503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex.
    Huang YS; Wang JT; Sheng WH; Chuang YC; Chang SC
    J Microbiol Immunol Infect; 2015 Oct; 48(5):545-51. PubMed ID: 24662017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.
    Drago L; De Vecchi E; Nicola L; Colombo A; Guerra A; Gismondo MR
    Chemotherapy; 2004 Oct; 50(4):202-10. PubMed ID: 15452399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.